Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1968 1
1969 1
1971 1
1974 1
1975 1
1977 2
1981 2
1982 2
1983 2
1984 3
1985 4
1986 3
1987 4
1988 3
1989 3
1990 10
1991 3
1992 3
1993 4
1994 10
1995 9
1996 8
1997 6
1998 10
1999 8
2000 5
2001 4
2002 11
2003 14
2004 9
2005 16
2006 12
2007 17
2008 17
2009 15
2010 17
2011 8
2012 25
2013 19
2014 18
2015 24
2016 12
2017 18
2018 22
2019 16
2020 12
2021 11
2022 18
2023 17
2024 13
2025 16
2026 8

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

445 results

Results by year

Filters applied: Meta-Analysis, Randomized Controlled Trial. Clear all
Page 1
The effects of antidepressants on cardiometabolic and other physiological parameters: a systematic review and network meta-analysis.
Pillinger T, Arumuham A, McCutcheon RA, D'Ambrosio E, Basdanis G, Branco M, Carr R, Finelli V, Furukawa TA, Gee S, Heald A, Jauhar S, Ma Z, Mancini V, Moulton C, Salanti G, Taylor DM, Tomlinson A, Young AH, Efthimiou O, Howes OD, Cipriani A. Pillinger T, et al. Lancet. 2025 Nov 1;406(10515):2063-2077. doi: 10.1016/S0140-6736(25)01293-0. Epub 2025 Oct 21. Lancet. 2025. PMID: 41135546 Free article.
We did frequentist random-effects network meta-analyses to investigate treatment-induced changes in weight; total cholesterol; glucose; heart rate; systolic and diastolic blood pressure; corrected QT interval (QTc); sodium; potassium; aspartate transferase (AST); al …
We did frequentist random-effects network meta-analyses to investigate treatment-induced changes in weight; total cholesterol; glucose; hear …
Memantine in moderate-to-severe Alzheimer's disease.
Reisberg B, Doody R, Stöffler A, Schmitt F, Ferris S, Möbius HJ; Memantine Study Group. Reisberg B, et al. N Engl J Med. 2003 Apr 3;348(14):1333-41. doi: 10.1056/NEJMoa013128. N Engl J Med. 2003. PMID: 12672860 Free article. Clinical Trial.
BACKGROUND: Overstimulation of the N-methyl-D-aspartate (NMDA) receptor by glutamate is implicated in neurodegenerative disorders. Accordingly, we investigated memantine, an NMDA antagonist, for the treatment of Alzheimer's disease. ...
BACKGROUND: Overstimulation of the N-methyl-D-aspartate (NMDA) receptor by glutamate is implicated in neurodegenerative disorders. Ac …
L-ornithine L-aspartate in acute treatment of severe hepatic encephalopathy: A double-blind randomized controlled trial.
Jain A, Sharma BC, Mahajan B, Srivastava S, Kumar A, Sachdeva S, Sonika U, Dalal A. Jain A, et al. Hepatology. 2022 May;75(5):1194-1203. doi: 10.1002/hep.32255. Epub 2021 Dec 21. Hepatology. 2022. PMID: 34822189 Clinical Trial.
BACKGROUND AND AIMS: Data on the use of intravenous L-ornithine L-aspartate (LOLA) in the treatment of overt HE (OHE) is limited. We evaluated the role of intravenous LOLA in patients of cirrhosis with OHE grade III-IV. ...
BACKGROUND AND AIMS: Data on the use of intravenous L-ornithine L-aspartate (LOLA) in the treatment of overt HE (OHE) is limited. We …
Pharmacological interventions for benzodiazepine discontinuation in chronic benzodiazepine users.
Baandrup L, Ebdrup BH, Rasmussen JØ, Lindschou J, Gluud C, Glenthøj BY. Baandrup L, et al. Cochrane Database Syst Rev. 2018 Mar 15;3(3):CD011481. doi: 10.1002/14651858.CD011481.pub2. Cochrane Database Syst Rev. 2018. PMID: 29543325 Free PMC article.
Alpidem decreased the proportion of participants with benzodiazepine discontinuation (1 study, 25 participants; RR 0.41, 95% CI 0.17 to 0.99; number needed to treat for an additional harmful outcome (NNTH) 2.3 participants; low-quality evidence) and increased the occurrence of wi …
Alpidem decreased the proportion of participants with benzodiazepine discontinuation (1 study, 25 participants; RR 0.41, 95% CI 0.17 to 0.99 …
Lithium Aspartate for Long COVID Fatigue and Cognitive Dysfunction: A Randomized Clinical Trial.
Guttuso T Jr, Zhu J, Wilding GE. Guttuso T Jr, et al. JAMA Netw Open. 2024 Oct 1;7(10):e2436874. doi: 10.1001/jamanetworkopen.2024.36874. JAMA Netw Open. 2024. PMID: 39356507 Free PMC article. Clinical Trial.
Intention-to-treat analysis was used. INTERVENTION: Lithium aspartate, 10 to 15 mg/d, or identically appearing placebo for 3 weeks followed by open-label lithium aspartate, 10 to 15 mg/d, for 2 weeks. ...RESULTS: Fifty-two participants were enrolled (30 [58%] males; …
Intention-to-treat analysis was used. INTERVENTION: Lithium aspartate, 10 to 15 mg/d, or identically appearing placebo for 3 weeks fo …
Resistance exercise effects on hippocampus subfield volumes and biomarkers of neuroplasticity and neuroinflammation in older adults with low and high risk of mild cognitive impairment: a randomized controlled trial.
Vints WAJ, Šeikinaitė J, Gökçe E, Kušleikienė S, Šarkinaite M, Valatkeviciene K, Česnaitienė VJ, Verbunt J, Levin O, Masiulis N. Vints WAJ, et al. Geroscience. 2024 Aug;46(4):3971-3991. doi: 10.1007/s11357-024-01110-6. Epub 2024 Mar 13. Geroscience. 2024. PMID: 38478179 Free PMC article. Clinical Trial.
Sodium L-Aspartate Supplementation Improves Repeated-Sprint Performance.
Yamaguchi K, Hayashi N, Sumi D, Ono M, Koizumi T, Sato W, Takeuchi F, Adachi Y, Goto K. Yamaguchi K, et al. Nutrients. 2023 Dec 15;15(24):5117. doi: 10.3390/nu15245117. Nutrients. 2023. PMID: 38140376 Free PMC article. Clinical Trial.
Aspartate supplementation has been reported to improve endurance performance by facilitating the tricarboxylic acid cycle flux. The present study was performed to investigate the effects of aspartate supplementation on repeated-sprint performance and blood pH …
Aspartate supplementation has been reported to improve endurance performance by facilitating the tricarboxylic acid cycle flux …
[Potassium substitution during coronary surgery: K(+)-Mg+(+)-aspartate-complex (Inzolen) versus potassium chloride].
Wulf H, Schulzeck S, Petry A, Hollander D. Wulf H, et al. Anaesthesiol Reanim. 1993;18(6):158-63. Anaesthesiol Reanim. 1993. PMID: 8297448 Clinical Trial. German.
Potassium loss may cause arrhythmias and cardiac injury in patients undergoing heart surgery with cardiopulmonary bypass (CPB). ...Patients received either potassium chloride (Group I, n = 102) or potassium magnesium aspartate (Inzolen, group II, n = 1 …
Potassium loss may cause arrhythmias and cardiac injury in patients undergoing heart surgery with cardiopulmonary bypass (CPB). ...Pa …
Prediction of Weight Loss and Regain Based on Multiomic and Phenotypic Features: Results From a Calorie-Restricted Feeding Trial.
Li L, Li R, Qiu Z, Zhu K, Li R, Zhao S, Che J, Guo T, Xu K, Geng T, Liao Y, Pan A, Liu G. Li L, et al. Diabetes Care. 2026 Jan 1;49(1):68-77. doi: 10.2337/dc25-0728. Diabetes Care. 2026. PMID: 40587116 Clinical Trial.
Several key baseline predictors, primarily gut microbes and fecal metabolites, such as N-acetyl-l-aspartic acid, Ruminococcus callidus, and Bifidobacterium adolescentis, were shared for weight and body composition changes during both phases. ...
Several key baseline predictors, primarily gut microbes and fecal metabolites, such as N-acetyl-l-aspartic acid, Ruminococcus …
445 results